Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest (Text with EEA relevance)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/regulation/2012/686@2012-07-26/en
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, and in particular Article 19, thereof,
Whereas:
(1) For active substances whose approval expires by 31 December 2018 at the latest, it is appropriate to allocate the evaluation for the purposes of the renewal procedures to the Member States, naming for each active substance a rapporteur and a co-rapporteur. That allocation should be made in such a way that a balance is achieved as regards the distribution of the responsibilities and the work between Member States.
(2) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS REGULATION:
Article 1
For the purposes of the renewal procedure, the evaluation of each active substance set out in the first column of the Annex, is allocated to a rapporteur Member State, as set out in the second column of that Annex, and to a co-rapporteur Member State, as set out in the third column of that Annex.
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 26 July 2012. For the Commission The President José Manuel Barroso
ANNEX
ANNEX
Active substance Rapporteur Member State Co-rapporteur Member State 1-methyl-cyclopropene UK PT 2,4-DB BE EL Acetamiprid NL ES Alpha-cypermethrin BE EL Amidosulfuron FI HR Ampelomyces quisqualis Strain: AQ 10 FR DE Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713 DE DK Beflubutamid DE LT Benalaxyl RO PT Benthiavalicarb PL FR Benzoic acid HU NL Beta-cyfluthrin DE HU Bifenazate SE IT Bifenox PL BE Bitertanol SE CZ Boscalid SK FR Bromoxynil FR DE Captan AT IT Carbendazim DE SI Carfentrazone ethyl BE FR Carvone NL SE Chloridazon DE PL Chlorothalonil NL BE Chlorotoluron BG FR Chlorpropham NL ES Chlorpyrifos ES PL Chlorpyrifos-methyl ES PL Clodinafop EL DE Clofentezine ES NL Clomazone DK DE Clopyralid FI PL Clothianidin DE ES Coniothyrium minitans Strain CON/M/91-08 (DSM 9660) NL EE Copper compounds FR DE Cyazofamid FR LV Cyfluthrin DE HU Cypermethrin BE DE Cyprodinil FR BG Daminozide CZ HU Deltamethrin UK AT Desmedipham FI DK Dicamba DK RO Dichlorprop-P IE PL Difenoconazole ES UK Diflubenzuron EL SK Diflufenican UK CZ Dimethenamid-P DE BG Dimethoate IT BG Dimethomorph PL DE Dimoxystrobin HU IE Diuron DE DK Ethephon NL PL Ethofumesate AT DK Ethoprophos IT IE Ethoxysulfuron IT AT Etoxazole EL UK Fenamidone CZ FR Fenamiphos EL CY Fenoxaprop-P AT FI Fenpropidin CZ DE Fipronil AT NL Flazasulfuron ES FR Fludioxonil FR ES Flufenacet PL FR Fluoxastrobin UK CZ Flurtamone CZ IE Folpet AT IT Foramsulfuron FI SK Forchlorfenuron ES EL Formetanate ES EL Fosetyl FR EE Fosthiazate DE EL Gliocladium catenulatum Strain: J1446 HU NL Glufosinate DE FR Imazamox FR IT Imazaquin BE IE Imazosulfuron SI FI Indoxacarb FR ES Iodosulfuron SE FI Ioxynil FR AT Iprodione FR BE Isoxaflutole IT SI Laminarin NL FR Lenacil BE AT Linuron IT DE Maleic hydrazide DK BE Mancozeb UK EL Maneb IT UK MCPA PL NL MCPB PL NL Mecoprop PL IE Mecoprop-P PL IE Mepanipyrim BE EL Mesosulfuron FR PL Mesotrione UK BE Metconazole BE UK Methiocarb UK DE Methoxyfenozide UK SK Metiram IT UK Metrafenone LV SK Metribuzin EE DE Milbemectin DE NL Molinate EL PT Nicosulfuron LV NL Oxadiargyl PL IT Oxadiazon IT ES Oxamyl IT FR Oxasulfuron IT AT Paecilomyces lilacinus (Thom) Samson 1974 strain 251 (AGAL: No 89/030550) HU NL Pendimethalin NL ES Pethoxamid AT CZ Phenmedipham FI DK Phosmet ES EL Picloram PL CZ Picoxystrobin CZ RO Pirimicarb UK SE Pirimiphos-methyl UK FR Propamocarb PT BE Propiconazole FI UK Propineb IT RO Propoxycarbazone SE EE Propyzamide SE UK Prosulfocarb PT SE Prothioconazole UK FR Pseudomonas chlororaphis Strain: MA 342 NL DK Pyraclostrobin DE HU Pyrimethanil CZ AT Pyriproxyfen NL ES Quinoclamine SE DE Quinoxyfen UK AT Rimsulfuron SI FI Silthiofam IE BE S-metolachlor DE FR Spinosad NL FR Spodoptera exigua nuclear polyhedrosis virus HU NL Tepraloxydim ES PL Thiacloprid UK DE Thiamethoxam FR ES Thiophanate-methyl SE FI Thiram FR BE Tolclofos-methyl SE DK Tribenuron SE LV Triclopyr PL HU Trifloxystrobin UK EL Trinexapac LT LV Triticonazole AT UK Tritosulfuron SI AT Warfarin SE DE Ziram IT MT Zoxamide LV FR
Versions
Cited by
- Commission Implementing Decision of 28 September 2016 on the establishment of a work programme for the assessment of applications for the renewal of approvals of active substances expiring in 2019, 2020 and 2021 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council 2016/C 357/05 Decision · Grade B
A large number of active substances deemed to have been approved in accordance with Regulation (EC) No 1107/2009 and listed in Part A of Annex to Regulation (EC) No 540/2011 have an expiry date set between 1 January 2019 and 31 December 2021. Part B of the Annex to Commission Implementing Regulation (EU) No 686/2012 lists those active substances and allocates to the Member States the evaluation of those active substances, naming for each active substance a rapporteur and a co-rapporteur Member State for the purposes of the renewal procedure.
- Commission Implementing Decision of 28 September 2016 on the establishment of a work programme for the assessment of applications for the renewal of approvals of active substances expiring in 2019, 2020 and 2021 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council 2016/C 357/05 Decision · Grade B
The work programme concerns active substances deemed to have been approved in accordance with Regulation (EC) No 1107/2009 which are listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012. The priorities for the assessment of applications for the renewal of approvals of the active substances and grouping together similar active substances, as provided for in Article 18 of Regulation (EC) No 1107/2009, are as follows:
- Commission Implementing Regulation (EU) 2019/150 of 30 January 2019 amending Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of the following active substances contained in plant protection products: deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole (Text with EEA relevance) Regulation · Grade B
Commission Implementing Regulation (EU) No 686/2012 allocated to the United Kingdom, as rapporteur Member State, the evaluation of certain active substances contained in plant protection products.
- Commission Implementing Regulation (EU) 2019/150 of 30 January 2019 amending Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of the following active substances contained in plant protection products: deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole (Text with EEA relevance) Regulation · Grade B
Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.
- Commission Implementing Regulation (EU) 2019/150 of 30 January 2019 amending Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of the following active substances contained in plant protection products: deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole (Text with EEA relevance) Regulation · Grade B
Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.
- Commission Implementing Regulation (EU) 2019/150 of 30 January 2019 amending Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of the following active substances contained in plant protection products: deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole (Text with EEA relevance) Regulation · Grade B
The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:
- Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (Text with EEA relevance) Regulation · Grade B
An application for the renewal of an approval of an active substance shall be submitted by a producer of the active substance to the rapporteur Member State, as set out in the second column of the Annex to Commission Implementing Regulation (EU) No 686/2012 and to the co-rapporteur Member State, as set out in the third column of that Annex, no later than three years before the expiry of the approval. When submitting an application, the applicant may, pursuant to Article 63 of Regulation (EC) No 1107/2009, request certain information to be kept confidential. In that event, the applicant shall p
- Commission Implementing Regulation (EU) 2026/398 of 18 February 2026 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-ol (Text with EEA relevance) Regulation · Grade B
Commission Implementing Regulation (EU) No 686/2012 allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. The evaluation of active substances whose approval expires between 31 January 2029 and 1 October 2035 was allocated to a rapporteur Member State and a co-rapporteur Member State by Commission Implementing Regulation (EU) 2023/543.
- Commission Implementing Regulation (EU) 2026/398 of 18 February 2026 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-ol (Text with EEA relevance) Regulation · Grade B
Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.
- Commission Implementing Regulation (EU) 2026/398 of 18 February 2026 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-ol (Text with EEA relevance) Regulation · Grade B
Part E of the Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:
- Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028 (Text with EEA relevance) Regulation · Grade B
Commission Implementing Regulation (EU) No 686/2012 allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. The evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028 was allocated to a rapporteur Member State and a co-rapporteur Member State. However, that allocation has not yet taken place for the evaluation of the active substance etoxazole, whose approval expires on 31 January 2028. It is therefore appropriate to proceed with such allocation.
- Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028 (Text with EEA relevance) Regulation · Grade B
Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.
- Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028 (Text with EEA relevance) Regulation · Grade B
In Part D of the Annex of Implementing Regulation (EU) No 686/2012, the following entry is inserted after the entry for Cyantraniliprole: Active substance Rapporteur Member State Co-rapporteur Member State Etoxazole FR EL
- Commission Implementing Regulation (EU) 2024/1734 of 21 June 2024 amending Implementing Regulation (EU) No 686/2012 as regards allocation to Member States, for the purposes of the renewal procedure, of the evaluation of the active substance deltamethrin (Text with EEA relevance) Regulation · Grade B
Commission Implementing Regulation (EU) No 686/2012 allocates the evaluation of the active substances deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole for the purposes of the renewal procedures to respective Member States, naming for each active substance a rapporteur and a co-rapporteur.
- Commission Implementing Regulation (EU) 2024/1734 of 21 June 2024 amending Implementing Regulation (EU) No 686/2012 as regards allocation to Member States, for the purposes of the renewal procedure, of the evaluation of the active substance deltamethrin (Text with EEA relevance) Regulation · Grade B
Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.
- Commission Implementing Regulation (EU) 2024/1734 of 21 June 2024 amending Implementing Regulation (EU) No 686/2012 as regards allocation to Member States, for the purposes of the renewal procedure, of the evaluation of the active substance deltamethrin (Text with EEA relevance) Regulation · Grade B
In Part A of the Annex to Implementing Regulation (EU) No 686/2012 the entry for Deltamethrin is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State Deltamethrin AT SE
- Commission Implementing Regulation (EU) 2016/183 of 11 February 2016 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest (Text with EEA relevance) Regulation · Grade B
Commission Implementing Regulation (EU) No 686/2012 allocates, for the purposes of the renewal procedures, the evaluation of active substances whose approval expires by 31 December 2018 at the latest to the Member States, naming for each active substance a rapporteur and a co-rapporteur. It is appropriate to allocate the evaluation of active substances whose approval expires by 31 December 2021 at the latest.
- Commission Implementing Regulation (EU) 2016/183 of 11 February 2016 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest (Text with EEA relevance) Regulation · Grade B
Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.
- Commission Implementing Regulation (EU) 2016/183 of 11 February 2016 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest (Text with EEA relevance) Regulation · Grade B
The Annex to Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.
- Commission Implementing Regulation (EU) 2016/183 of 11 February 2016 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest (Text with EEA relevance) Regulation · Grade B
Implementing Regulation (EU) No 686/2012 is amended as follows: